Developer docs
API playgroundTry for free, no card

Search company profiles

Regemat 3D

Full company profile

uuid00047bg

Namestring
Regemat 3D
Legal namestring
REGEMAT 3D S.L.
Websiteurl
regemat3d.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Regemat 3D (legal entity REGEMAT 3D S.L.) is a privately held Spanish biomedical technology company founded in 2015 and headquartered in Armilla (Granada), Spain, with a team in the 11–50 range. It develops and sells an integrated tissue engineering platform that pairs 3D bioprinting hardware with bioreactor systems, biomaterials, and software, positioning itself as the only vendor offering an end-to-end workflow that takes printed constructs from scaffold to functional living tissue rather than stopping at scaffold fabrication.

The core product portfolio includes the BIO V1 and REG4Life modular bioprinters, the patented BMAP® Knee Bioreactor (the only commercial bioreactor specifically designed for cartilage tissue maturation and osteochondral regeneration), the GelMA-Graphene Kit (an electroconductive bioink co-developed with Graphenano and Tessenderlo Group), R3D Studio bioprinting software, and a Virtual Reality Training Platform described as the first of its kind for 3D bioprinting. Supporting revenue lines span photoinitiators and other reagents, hydrogels, thermoplastics, consumables, and a portfolio of protocols via LabMethods.org. The customer base is concentrated in academic and government research institutions (e.g., University of Erlangen-Nuremberg, National Eye Institute, University of Iowa, Politecnico di Torino, several Spanish universities), with secondary exposure to healthcare/medical and pharmaceutical customers pursuing drug-delivery and personalized medicine use cases.

The business model is enterprise hardware-led with a hybrid GTM: direct field sales through business developers for major equipment purchases (quote-based, no public pricing), regional distribution partnerships covering Spain (Palex), Italy (Schaefer SEE), the CEE region (SEQme), and Egypt/MENA (MiraLab), plus a self-serve e-commerce storefront for reagents and consumables. Revenue is also supplemented by recurring software licensing, intensive training courses (e.g., 35-hour 3D Bioprinting & Cell Culture Course), and turnkey lab setup services. The company has executed two Crowdcube funding rounds totaling approximately $1.1M (2020 and 2022), received a Torres Quevedo fellowship from the Spanish State Research Agency in 2024, and participates in EU-funded consortia (REBORN Project, inkjet-bioAM Project); revenue and valuation are not publicly disclosed.

Short descriptiontext

Regemat 3D is a Spanish biomedical company that sells an integrated 3D bioprinting and bioreactor platform for regenerative medicine research. It serves academic, government, and healthcare laboratories in 35+ countries with customizable bioprinters, the patented BMAP® Knee Bioreactor, proprietary bioinks, software, and training services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGranada, Spain
HQ citystring
Granada
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
3D bioprinting systems, bioreactor equipment, tissue engineering products, biofabrication solutions, regenerative medicine tools
Industry4 codes
PRIMARYIMAAAAAG
Bioprinting & Biofabrication Systems (Tissue/Cell Printing Hardware)
Industrials, Manufacturing & Construction/3D Printing/3D Printing Hardware (Printers & Systems)
SECONDARYHLAAAGAC
3D Bioprinting & Biofabrication
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAAGAH
Cartilage, Bone & Musculoskeletal Regeneration
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAAGAB
Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
NAICS code4 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Scientific Research and Development Services5417
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
3D Bioprinting and Tissue Engineering Equipment
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model6 records
13D Bioprinters
TypeHardware Sales
Description

Sale of modular bioprinters (BioV1, REG4Life) designed for research and biofabrication applications. Fully customizable systems targeting research institutions and companies.

regemat3d.com
2Bioreactors
TypeHardware Sales
Description

Sale of specialized bioreactors including the patented BMAP® Knee Bioreactor for cartilage tissue maturation. Premium-priced specialized equipment.

regemat3d.com
3Bioinks and Biomaterials
TypeHardware Sales
Description

Sale of specialized bioinks including the GelMA-Graphene Kit, hydrogels, thermoplastics, and polymerization initiators.

regemat3d.com
4Reagents and Consumables
TypeHardware Sales
Description

Photoinitiators (LAP, IRGACURE 2959, RU(BPY)3), cell culture reagents, dispensing tips, syringe barrels, pistons, and connectors.

regemat3d.com
5Software Licenses
TypeSubscription Recurring
Description

Sale of R3D Studio bioprinting software with advanced design and visualization capabilities.

regemat3d.com
6Training and Services
TypeProfessional Services
Description

Onsite courses (3D Bioprinting & Cell Culture, 35-hour intensive programs), turnkey lab setup services, and technical support.

regemat3d.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Enterprise/B2B hardware and software solutions
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Prices not publicly disclosed; requires contact for quote. E-commerce site shows 'Log in to see the price' for most products.

regemat3d.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

REGEMAT 3D designs, manufactures, and sells modular 3D bioprinters (BioV1, REG4Life), the patented BMAP® Knee Bioreactor for cartilage tissue maturation, bioprinting software (R3D Studio) and a VR Training Platform, alongside biomaterials (GelMA-Graphene bioink), reagents (LAP, IRGACURE 2959, RU(BPY)3), consumables, training courses, and turnkey biofabrication laboratory setup services for regenerative medicine researchers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Functional cartilage tissue maturation in weeks through bioreactor stimulation
+1 more record
Product overview1 text field

Regemat 3D offers an integrated tissue engineering platform combining hardware, software, biomaterials, and services. The core portfolio includes two 3D bioprinters (BIO V1 and REG4Life), the patented BMAP® Knee Bioreactor for cartilage maturation, R3D Studio software for design and control, and a VR Training Platform for immersive learning. Supporting products include a range of reagents (photoinitiators LAP, IRGACURE 2959, RU(BPY)3; crosslinker Calcium Chloride; assay kits), consumables (dispensing tips, syringes), and the GelMA-Graphene electroconductive bioink. Services encompass training courses and turnkey lab setup. The platform enables end-to-end tissue engineering from scaffold printing through tissue maturation.

Product and service16 records
1BIO V1 Bioprinter
Category3D Bioprinter
Description

A modular 3D bioprinter designed for advanced research and biofabrication, compatible with a wide range of biomaterials, printing surfaces, and extrusion technologies. Targeted at tissue engineering and regenerative medicine researchers.

2REG4Life Bioprinter
Category3D Bioprinter
Description

A fully customizable 3D bioprinter for advanced research with adaptable extrusion systems, temperature settings, and other key parameters to meet specific research requirements. Targeted at laboratories needing tailored biofabrication capabilities.

3BMAP® Knee Bioreactor
CategoryBioreactor
Description

The only patented bioreactor system specifically designed for osteochondral regeneration. Replicates physiological conditions of the human knee, applies controlled movements to transform 3D-printed scaffolds into functional cartilage tissue. Targeted at clinical tissue engineering and cartilage regeneration research.

4R3D Studio Software
CategorySoftware
Description

Next-generation bioprinting software for the tissue engineering and regenerative medicine community. Features intuitive interface, advanced scaffold customization, enhanced visualization with trajectory preview, and seamless STL/G-code file handling.

5VR Training Platform for 3D Bioprinting
CategorySoftware
Description

First Virtual Reality training platform specifically developed for 3D bioprinting. Provides step-by-step interactive training across protocols including 3D bioprinting, bioink preparation, and 3D cell culture techniques.

6GelMA-Graphene Kit
CategoryBiomaterial / Bioink
Description

The only electroconductive bioink based on GelMA for advanced tissue engineering applications. Co-developed with Graphenano and Tessenderlo Group. Features customizable GelMA, LAP, and graphene concentrations for adapting mechanical and biological properties to specific tissues.

7GelMA-Graphene Hydrogel
CategoryBiomaterial / Bioink
Description

World's only GelMA-Graphene hydrogel. Revolutionary electroconductive bioink developed for next-generation tissue engineering applications, validated by leading Spanish universities.

8LAP (Lithium phenyl-2,4,6-trimethylbenzoylphosphinate)
CategoryReagent
Description

Water-soluble, cytocompatible photoinitiator ideal for crosslinking methacrylated hydrogels in 3D bioprinting and tissue engineering. Activated at 365 nm and 405 nm for faster polymerization with improved cell viability.

9IRGACURE 2959
CategoryReagent
Description

High-purity UV photoinitiator optimized for crosslinking methacrylated hydrogels (GelMA, HumaDerMA®, OsteoGelMA®) in 3D bioprinting and tissue engineering. Activated at 365 nm.

10RU(BPY)3 and SPS
CategoryReagent
Description

Visible light-activated photoinitiator (≥400 nm, optimal at 450 nm) for gentle crosslinking of biomaterials like GelMA, collagen, and silk fibroin, ensuring high cell viability.

11Calcium Chloride (CaCl₂)
CategoryReagent
Description

High-purity ionic crosslinker essential for rapid gelation of alginate-based bioinks in 3D bioprinting and tissue engineering. Enables stable hydrogel formation.

12Cyto3D Live-Dead Assay Kit
CategoryReagent / Assay Kit
Description

Versatile assay to determine live/dead nucleated cells using a quick one-step staining procedure with Acridine orange (AO) and Propidium Iodide (PI) for dual-fluorescence analysis.

13VitroGel® Organoid Recovery Solution
CategoryReagent / Recovery Solution
Description

Non-enzymatic cell harvesting solution for recovering cells/organoids from hydrogel or animal-based ECM. Less than 15-minute cell recovery protocol.

14Dispensing Tips
CategoryConsumable
Description

Dispensing tips ensuring accurate and controlled bioink extrusion. Available in polypropylene (conical) and stainless steel (straight) designs for clog-free printing.

153D Bioprinting & Cell Culture Course
CategoryTraining Service
Description

Intensive onsite 35-hour course offering theoretical and practical sessions in biofabrication, biomaterials, and tissue engineering. Includes hands-on lab sessions and technology demonstrations for researchers and professionals.

16Turnkey Lab Service
CategoryProfessional Service
Description

Fully equipped lab setup and technical support services for establishing biofabrication laboratories, including continuous technical assistance.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership19 partners
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2025-04-08
Description

Strategic visit to Egypt to engage with key academic and scientific institutions. Discussions on future of 3D bioprinting and biotechnology in the region. Part of MENA expansion strategy.

2inkjet-bioAM Project Consortium
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2025-04-01
Description

EU-funded project consortium including PROFACTOR, Research Center Pharmaceutical Engineering GmbH, University of Graz, Tiger Coatings, Infineon Technologies, and 8 other partners. REGEMAT 3D hosted the General Meeting welcoming 22 experts from five countries.

regemat3d.com
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2025-01-24
Description

Dr. María José López Andreo from Universidad de Murcia visited REGEMAT 3D's Biofabrication Laboratory to explore 3D bioprinting technologies and gain hands-on experience with advanced biofabrication tools.

4Leartiker
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2024-11-22
Description

Collaborative research initiative focused on developing a 3D bioprinted in vitro cartilage model using mesenchymal stem cells (MSCs) and promoting their differentiation into chondrocytes. Hosted Izar Gorroñogoitia at REGEMAT 3D's Biofabrication Laboratory.

regemat3d.com
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-07-24
Description

Distribution agreement for Italy. Schaefer SEE Srl is an official distributor of REGEMAT 3D products, hosting hands-on workshops and providing local support. Representatives participated in REGEMAT 3D's 3D Bioprinting & Cell Culture Course.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-07-24
Description

Distribution agreement extending coverage to Poland, Czech Republic, and Slovakia. Both SEQme representatives participated in REGEMAT 3D's training course, demonstrating commitment to biofabrication solutions.

7REBORN Project Consortium
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-07-08
Description

European research consortium focused on advancing biofabrication. REGEMAT 3D participated in M18 review meeting in Porto hosted by Universidade do Porto and i3S-Instituto de Investigação e Inovação em Saúde. CEO attended General Assembly in Berlin (January 2025).

regemat3d.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Exclusive distributor in Spain. Supported REGEMAT 3D's participation in III Congreso de Investigación PTS Granada, one of Spain's premier biomedical events.

9University of Erlangen-Nuremberg (Institute of Biomaterials)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration with Prof. Aldo R. Boccaccini and Dr. Rainer Detsch for hosting biofabrication workshop. The workshop demonstrated REGEMAT 3D's bioprinters, bioreactors, and VR training platform to researchers and faculty.

regemat3d.com
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Co-development partner for the GelMA-Graphene Kit, the world's only electroconductive GelMA-based bioink. Graphenano contributed graphene technology for advanced tissue engineering applications.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Co-development partner for the GelMA-Graphene Kit, contributing to the unique electroconductive bioink formulation for tissue engineering.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Local distributor in Egypt alongside the MSA University visit, supporting regional expansion in the MENA market.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Research collaboration on multimaterial synthetic bone grafts using REGEMAT 3D bioprinter. Publication describes development of gelatin-coated, 3D-printed PCL scaffolds for enhanced bone defect regeneration through sustained delivery of miR-200c.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Research team led by Gloria Mora Castaño used REGEMAT 3D's BioV1 bioprinter to develop 3D printed gastroretentive floating tablets for controlled drug release. Collaboration with An Najah National University and Ghent University.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Scientists at NEI successfully 3D bioprinted functional eye tissue, marking transformative advancement in regenerative medicine and vision restoration using REGEMAT 3D technologies.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Validation partner for GelMA-Graphene hydrogel. Prof. Juan Antonio Marchal from University of Granada collaborates on research and presented at PTS Granada Congress.

17University of Barcelona
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Validation partner for the GelMA-Graphene hydrogel alongside University of Granada and University of Alcalá.

regemat3d.com
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Validation partner for the GelMA-Graphene hydrogel alongside University of Granada and University of Barcelona.

19OnGranada Tech City
Strategic tierSupportTypeOthers
Description

Local innovation cluster providing support to REGEMAT 3D as part of the inkjet-bioAM project and broader regional ecosystem development.

regemat3d.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

3D Biotek develops 3D bioprinting and tissue engineering technologies, including scaffolds and bioprinters for research applications. Comparable niche player to Regemat 3D in product portfolio and academic customer base.

TypeDirect peer
Description

CELLINK, now part of BICO, is one of the leading commercial suppliers of 3D bioprinters, bioinks, and consumables for regenerative medicine research. Directly comparable to Regemat 3D in target customers (research institutions), product portfolio (bioprinters + bioinks), and business model (hardware + consumables), but operates at substantially greater scale.

TypeDirect peer
Description

Allevi, acquired by 3D Systems, develops desktop 3D bioprinters and bioinks widely used in academic tissue engineering labs. Competes head-to-head with Regemat's BioV1 and REG4Life systems in the same research institution buyer segment.

4Aspect Biosystems
TypeDirect peer
Description

Aspect Biosystems develops microfluidic 3D bioprinting platforms for tissue engineering and regenerative medicine, with a focus on therapeutic applications. Comparable to Regemat 3D in mission (creating functional living tissues) and target market (research and pharma/biotech), though differentiated technology.

TypeDirect peer
Description

RegenHU is a Swiss manufacturer of modular 3D bioprinters and bioinks for tissue engineering and regenerative medicine research. Highly comparable to Regemat 3D in product type (modular bioprinters), customer segment (academic and pharma research), and emphasis on customization.

TypeDirect peer
Description

Poietis is a French biotechnology company specializing in laser-assisted 3D bioprinting for tissue engineering. Direct peer in the bioprinting hardware space serving similar regenerative medicine research customers in Europe.

TypeDirect peer
Description

Organovo is a pioneer in 3D bioprinting of functional human tissues for therapeutic and research applications. Comparable to Regemat 3D in tissue engineering focus, though Organovo is more drug-discovery oriented and has undergone significant restructuring.

TypeRegional player
Description

GeSiM is a German manufacturer of specialized 3D bioprinters and micro-dosing systems for life science research. Comparable to Regemat 3D in product type (modular bioprinters for research), with strong overlap in European academic customer base though based in Germany rather than Spain.

TypeDirect peer
Description

Brinter is a Finnish 3D bioprinter company offering modular bioprinting systems for tissue engineering and pharmaceutical research. Comparable in product positioning (modular multi-material bioprinters) and customer base, but a regional European peer.

TypeBroad incumbent
Description

Stratasys is a global leader in 3D printing with biomedical applications including research-grade printing solutions. A broad incumbent in 3D printing that overlaps with Regemat 3D's research customer base, though Stratasys is not specialized in bioprinting/living tissue fabrication.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Regemat 3D

3D Bioprinting and Tissue Engineering Equipmentregemat3d.com

Regemat 3D is a Spanish biomedical company that sells an integrated 3D bioprinting and bioreactor platform for regenerative medicine research. It serves academic, government, and healthcare laboratories in 35+ countries with customizable bioprinters, the patented BMAP® Knee Bioreactor, proprietary bioinks, software, and training services.

What Regemat 3D does

Regemat 3D (legal entity REGEMAT 3D S.L.) is a privately held Spanish biomedical technology company founded in 2015 and headquartered in Armilla (Granada), Spain, with a team in the 11–50 range. It develops and sells an integrated tissue engineering platform that pairs 3D bioprinting hardware with bioreactor systems, biomaterials, and software, positioning itself as the only vendor offering an end-to-end workflow that takes printed constructs from scaffold to functional living tissue rather than stopping at scaffold fabrication.

The core product portfolio includes the BIO V1 and REG4Life modular bioprinters, the patented BMAP® Knee Bioreactor (the only commercial bioreactor specifically designed for cartilage tissue maturation and osteochondral regeneration), the GelMA-Graphene Kit (an electroconductive bioink co-developed with Graphenano and Tessenderlo Group), R3D Studio bioprinting software, and a Virtual Reality Training Platform described as the first of its kind for 3D bioprinting. Supporting revenue lines span photoinitiators and other reagents, hydrogels, thermoplastics, consumables, and a portfolio of protocols via LabMethods.org. The customer base is concentrated in academic and government research institutions (e.g., University of Erlangen-Nuremberg, National Eye Institute, University of Iowa, Politecnico di Torino, several Spanish universities), with secondary exposure to healthcare/medical and pharmaceutical customers pursuing drug-delivery and personalized medicine use cases.

The business model is enterprise hardware-led with a hybrid GTM: direct field sales through business developers for major equipment purchases (quote-based, no public pricing), regional distribution partnerships covering Spain (Palex), Italy (Schaefer SEE), the CEE region (SEQme), and Egypt/MENA (MiraLab), plus a self-serve e-commerce storefront for reagents and consumables. Revenue is also supplemented by recurring software licensing, intensive training courses (e.g., 35-hour 3D Bioprinting & Cell Culture Course), and turnkey lab setup services. The company has executed two Crowdcube funding rounds totaling approximately $1.1M (2020 and 2022), received a Torres Quevedo fellowship from the Spanish State Research Agency in 2024, and participates in EU-funded consortia (REBORN Project, inkjet-bioAM Project); revenue and valuation are not publicly disclosed.

Regemat 3D firmographics

Firmographics
Name
Regemat 3D
Legal name
REGEMAT 3D S.L.
Website
https://regemat3d.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
Regemat 3D is a Spanish biomedical company that sells an integrated 3D bioprinting and bioreactor platform for regenerative medicine research. It serves academic, government, and healthcare laboratories in 35+ countries with customizable bioprinters, the patented BMAP® Knee Bioreactor, proprietary bioinks, software, and training services.
Ownership category
akta.pro rank

Regemat 3D industry classification

Industry
Product category
3D Bioprinting and Tissue Engineering Equipment
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYIMAAAAAG
Bioprinting & Biofabrication Systems (Tissue/Cell Printing Hardware)
Industrials, Manufacturing & Construction/3D Printing/3D Printing Hardware (Printers & Systems)
SECONDARYHLAAAGAC
3D Bioprinting & Biofabrication
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAAGAH
Cartilage, Bone & Musculoskeletal Regeneration
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAAGAB
Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering

Keywords

  • 3D bioprinting systems
  • Bioreactor equipment
  • Tissue engineering products
  • Biofabrication solutions
  • Regenerative medicine tools

Where Regemat 3D is headquartered

Location

Headquarters

HQ city
Granada
HQ country
Spain
HQ region
Europe

Offices2 records

Markets served

Regemat 3D business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. 3D Bioprinters: Sale of modular bioprinters (BioV1, REG4Life) designed for research and biofabrication applications. Fully customizable systems targeting research institutions and companies.
  2. Bioreactors: Sale of specialized bioreactors including the patented BMAP® Knee Bioreactor for cartilage tissue maturation. Premium-priced specialized equipment.
  3. Bioinks and Biomaterials: Sale of specialized bioinks including the GelMA-Graphene Kit, hydrogels, thermoplastics, and polymerization initiators.
  4. Reagents and Consumables: Photoinitiators (LAP, IRGACURE 2959, RU(BPY)3), cell culture reagents, dispensing tips, syringe barrels, pistons, and connectors.
  5. Software Licenses: Sale of R3D Studio bioprinting software with advanced design and visualization capabilities.
  6. Training and Services: Onsite courses (3D Bioprinting & Cell Culture, 35-hour intensive programs), turnkey lab setup services, and technical support.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractEnterprise/B2B hardware and software solutions

Go-to-market motion3 records

Distribution channels6 records

Marketing channels7 records

Regemat 3D product offering

Product offering

Core offering

REGEMAT 3D designs, manufactures, and sells modular 3D bioprinters (BioV1, REG4Life), the patented BMAP® Knee Bioreactor for cartilage tissue maturation, bioprinting software (R3D Studio) and a VR Training Platform, alongside biomaterials (GelMA-Graphene bioink), reagents (LAP, IRGACURE 2959, RU(BPY)3), consumables, training courses, and turnkey biofabrication laboratory setup services for regenerative medicine researchers.

Product overview

Regemat 3D offers an integrated tissue engineering platform combining hardware, software, biomaterials, and services. The core portfolio includes two 3D bioprinters (BIO V1 and REG4Life), the patented BMAP® Knee Bioreactor for cartilage maturation, R3D Studio software for design and control, and a VR Training Platform for immersive learning. Supporting products include a range of reagents (photoinitiators LAP, IRGACURE 2959, RU(BPY)3; crosslinker Calcium Chloride; assay kits), consumables (dispensing tips, syringes), and the GelMA-Graphene electroconductive bioink. Services encompass training courses and turnkey lab setup. The platform enables end-to-end tissue engineering from scaffold printing through tissue maturation.

Differentiator

Problem solved

Functional benefit

Products and services

  • BIO V1 Bioprinter A modular 3D bioprinter designed for advanced research and biofabrication, compatible with a wide range of biomaterials, printing surfaces, and extrusion technologies. Targeted at tissue engineering and regenerative medicine researchers.
  • REG4Life Bioprinter A fully customizable 3D bioprinter for advanced research with adaptable extrusion systems, temperature settings, and other key parameters to meet specific research requirements. Targeted at laboratories needing tailored biofabrication capabilities.
  • BMAP® Knee Bioreactor The only patented bioreactor system specifically designed for osteochondral regeneration. Replicates physiological conditions of the human knee, applies controlled movements to transform 3D-printed scaffolds into functional cartilage tissue. Targeted at clinical tissue engineering and cartilage regeneration research.
  • R3D Studio Software Next-generation bioprinting software for the tissue engineering and regenerative medicine community. Features intuitive interface, advanced scaffold customization, enhanced visualization with trajectory preview, and seamless STL/G-code file handling.
  • VR Training Platform for 3D Bioprinting First Virtual Reality training platform specifically developed for 3D bioprinting. Provides step-by-step interactive training across protocols including 3D bioprinting, bioink preparation, and 3D cell culture techniques.
  • GelMA-Graphene Kit The only electroconductive bioink based on GelMA for advanced tissue engineering applications. Co-developed with Graphenano and Tessenderlo Group. Features customizable GelMA, LAP, and graphene concentrations for adapting mechanical and biological properties to specific tissues.
  • GelMA-Graphene Hydrogel World's only GelMA-Graphene hydrogel. Revolutionary electroconductive bioink developed for next-generation tissue engineering applications, validated by leading Spanish universities.
  • LAP (Lithium phenyl-2,4,6-trimethylbenzoylphosphinate) Water-soluble, cytocompatible photoinitiator ideal for crosslinking methacrylated hydrogels in 3D bioprinting and tissue engineering. Activated at 365 nm and 405 nm for faster polymerization with improved cell viability.
  • IRGACURE 2959 High-purity UV photoinitiator optimized for crosslinking methacrylated hydrogels (GelMA, HumaDerMA®, OsteoGelMA®) in 3D bioprinting and tissue engineering. Activated at 365 nm.
  • RU(BPY)3 and SPS Visible light-activated photoinitiator (≥400 nm, optimal at 450 nm) for gentle crosslinking of biomaterials like GelMA, collagen, and silk fibroin, ensuring high cell viability.
  • Calcium Chloride (CaCl₂) High-purity ionic crosslinker essential for rapid gelation of alginate-based bioinks in 3D bioprinting and tissue engineering. Enables stable hydrogel formation.
  • Cyto3D Live-Dead Assay Kit Versatile assay to determine live/dead nucleated cells using a quick one-step staining procedure with Acridine orange (AO) and Propidium Iodide (PI) for dual-fluorescence analysis.
  • VitroGel® Organoid Recovery Solution Non-enzymatic cell harvesting solution for recovering cells/organoids from hydrogel or animal-based ECM. Less than 15-minute cell recovery protocol.
  • Dispensing Tips Dispensing tips ensuring accurate and controlled bioink extrusion. Available in polypropylene (conical) and stainless steel (straight) designs for clog-free printing.
  • 3D Bioprinting & Cell Culture Course Intensive onsite 35-hour course offering theoretical and practical sessions in biofabrication, biomaterials, and tissue engineering. Includes hands-on lab sessions and technology demonstrations for researchers and professionals.
  • Turnkey Lab Service Fully equipped lab setup and technical support services for establishing biofabrication laboratories, including continuous technical assistance.

Quantifiable outcome

  • Functional cartilage tissue maturation in weeks through bioreactor stimulation
  • +1 more outcomes

Companies that use Regemat 3D

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles3 records

Regemat 3D technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature9 records

Regemat 3D partnerships and signals

Strategic signal

Partnerships

19 partnerships are on record, tiered strategic, core, flagship and support.

  • MSA University CairostrategicStrategic or Co-development Partner · 8 April 2025Strategic visit to Egypt to engage with key academic and scientific institutions. Discussions on future of 3D bioprinting and biotechnology in the region. Part of MENA expansion strategy.
  • inkjet-bioAM Project ConsortiumstrategicStrategic or Co-development Partner · 1 April 2025EU-funded project consortium including PROFACTOR, Research Center Pharmaceutical Engineering GmbH, University of Graz, Tiger Coatings, Infineon Technologies, and 8 other partners. REGEMAT 3D hosted the General Meeting welcoming 22 experts from five countries.
  • Universidad de MurciastrategicStrategic or Co-development Partner · 24 January 2025Dr. María José López Andreo from Universidad de Murcia visited REGEMAT 3D's Biofabrication Laboratory to explore 3D bioprinting technologies and gain hands-on experience with advanced biofabrication tools.
  • LeartikerstrategicStrategic or Co-development Partner · 22 November 2024Collaborative research initiative focused on developing a 3D bioprinted in vitro cartilage model using mesenchymal stem cells (MSCs) and promoting their differentiation into chondrocytes. Hosted Izar Gorroñogoitia at REGEMAT 3D's Biofabrication Laboratory.
  • Schaefer SEE SrlcoreChannel Partner/ Reseller/ Distributor · 24 July 2024Distribution agreement for Italy. Schaefer SEE Srl is an official distributor of REGEMAT 3D products, hosting hands-on workshops and providing local support. Representatives participated in REGEMAT 3D's 3D Bioprinting & Cell Culture Course.
  • SEQme s.r.o.coreChannel Partner/ Reseller/ Distributor · 24 July 2024Distribution agreement extending coverage to Poland, Czech Republic, and Slovakia. Both SEQme representatives participated in REGEMAT 3D's training course, demonstrating commitment to biofabrication solutions.
  • REBORN Project ConsortiumflagshipStrategic or Co-development Partner · 8 July 2024European research consortium focused on advancing biofabrication. REGEMAT 3D participated in M18 review meeting in Porto hosted by Universidade do Porto and i3S-Instituto de Investigação e Inovação em Saúde. CEO attended General Assembly in Berlin (January 2025).
  • Palex EspañacoreChannel Partner/ Reseller/ DistributorExclusive distributor in Spain. Supported REGEMAT 3D's participation in III Congreso de Investigación PTS Granada, one of Spain's premier biomedical events.
  • University of Erlangen-Nuremberg (Institute of Biomaterials)coreStrategic or Co-development PartnerCollaboration with Prof. Aldo R. Boccaccini and Dr. Rainer Detsch for hosting biofabrication workshop. The workshop demonstrated REGEMAT 3D's bioprinters, bioreactors, and VR training platform to researchers and faculty.
  • GraphenanoflagshipStrategic or Co-development PartnerCo-development partner for the GelMA-Graphene Kit, the world's only electroconductive GelMA-based bioink. Graphenano contributed graphene technology for advanced tissue engineering applications.
  • Tessenderlo GroupflagshipStrategic or Co-development PartnerCo-development partner for the GelMA-Graphene Kit, contributing to the unique electroconductive bioink formulation for tissue engineering.
  • MiraLab (Lab Equipment)coreChannel Partner/ Reseller/ DistributorLocal distributor in Egypt alongside the MSA University visit, supporting regional expansion in the MENA market.
  • University of IowastrategicStrategic or Co-development PartnerResearch collaboration on multimaterial synthetic bone grafts using REGEMAT 3D bioprinter. Publication describes development of gelatin-coated, 3D-printed PCL scaffolds for enhanced bone defect regeneration through sustained delivery of miR-200c.
  • Universidad de SevillastrategicStrategic or Co-development PartnerResearch team led by Gloria Mora Castaño used REGEMAT 3D's BioV1 bioprinter to develop 3D printed gastroretentive floating tablets for controlled drug release. Collaboration with An Najah National University and Ghent University.
  • National Eye Institute (NEI)strategicStrategic or Co-development PartnerScientists at NEI successfully 3D bioprinted functional eye tissue, marking transformative advancement in regenerative medicine and vision restoration using REGEMAT 3D technologies.
  • University of GranadastrategicStrategic or Co-development PartnerValidation partner for GelMA-Graphene hydrogel. Prof. Juan Antonio Marchal from University of Granada collaborates on research and presented at PTS Granada Congress.
  • University of BarcelonastrategicStrategic or Co-development PartnerValidation partner for the GelMA-Graphene hydrogel alongside University of Granada and University of Alcalá.
  • University of AlcalástrategicStrategic or Co-development PartnerValidation partner for the GelMA-Graphene hydrogel alongside University of Granada and University of Barcelona.
  • OnGranada Tech CitysupportOthersLocal innovation cluster providing support to REGEMAT 3D as part of the inkjet-bioAM project and broader regional ecosystem development.

Scale indicators5 records

Recent moves8 records

Expansion highlights5 records

Regemat 3D competitors and assessment

Company assessment

Direct peers

  • 3D Biotek: 3D Biotek develops 3D bioprinting and tissue engineering technologies, including scaffolds and bioprinters for research applications. Comparable niche player to Regemat 3D in product portfolio and academic customer base.
  • CELLINK (BICO): CELLINK, now part of BICO, is one of the leading commercial suppliers of 3D bioprinters, bioinks, and consumables for regenerative medicine research. Directly comparable to Regemat 3D in target customers (research institutions), product portfolio (bioprinters + bioinks), and business model (hardware + consumables), but operates at substantially greater scale.
  • Allevi (3D Systems): Allevi, acquired by 3D Systems, develops desktop 3D bioprinters and bioinks widely used in academic tissue engineering labs. Competes head-to-head with Regemat's BioV1 and REG4Life systems in the same research institution buyer segment.
  • Aspect Biosystems: Aspect Biosystems develops microfluidic 3D bioprinting platforms for tissue engineering and regenerative medicine, with a focus on therapeutic applications. Comparable to Regemat 3D in mission (creating functional living tissues) and target market (research and pharma/biotech), though differentiated technology.
  • RegenHU: RegenHU is a Swiss manufacturer of modular 3D bioprinters and bioinks for tissue engineering and regenerative medicine research. Highly comparable to Regemat 3D in product type (modular bioprinters), customer segment (academic and pharma research), and emphasis on customization.
  • Poietis: Poietis is a French biotechnology company specializing in laser-assisted 3D bioprinting for tissue engineering. Direct peer in the bioprinting hardware space serving similar regenerative medicine research customers in Europe.
  • Organovo: Organovo is a pioneer in 3D bioprinting of functional human tissues for therapeutic and research applications. Comparable to Regemat 3D in tissue engineering focus, though Organovo is more drug-discovery oriented and has undergone significant restructuring.
  • Brinter: Brinter is a Finnish 3D bioprinter company offering modular bioprinting systems for tissue engineering and pharmaceutical research. Comparable in product positioning (modular multi-material bioprinters) and customer base, but a regional European peer.

Regional players

  • GeSiM (Gesellschaft für Silizium-Mikrosysteme): GeSiM is a German manufacturer of specialized 3D bioprinters and micro-dosing systems for life science research. Comparable to Regemat 3D in product type (modular bioprinters for research), with strong overlap in European academic customer base though based in Germany rather than Spain.

Broad incumbents

  • Stratasys: Stratasys is a global leader in 3D printing with biomedical applications including research-grade printing solutions. A broad incumbent in 3D printing that overlaps with Regemat 3D's research customer base, though Stratasys is not specialized in bioprinting/living tissue fabrication.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Regemat 3D social profiles

Digital presence

Regemat 3D financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Regemat 3D leadership team

Management profile

Number of profiles

Profiles8 records

Regemat 3D funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Regemat 3D M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Regemat 3D

What does Regemat 3D do?

REGEMAT 3D designs, manufactures, and sells modular 3D bioprinters (BioV1, REG4Life), the patented BMAP® Knee Bioreactor for cartilage tissue maturation, bioprinting software (R3D Studio) and a VR Training Platform, alongside biomaterials (GelMA-Graphene bioink), reagents (LAP, IRGACURE 2959, RU(BPY)3), consumables, training courses, and turnkey biofabrication laboratory setup services for regenerative medicine researchers.

Is Regemat 3D a public or private company?

Regemat 3D is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Regemat 3D founded?

Regemat 3D was founded in 2015. It employs 11 to 50 people.

Where is Regemat 3D based?

Regemat 3D is headquartered in Granada, Spain, in the Europe region.

How does Regemat 3D make money?

Six revenue lines are on record. 3D Bioprinters are the primary driver. The others are bioreactors, bioinks and Biomaterials, reagents and Consumables, software Licenses and training and Services.

Who are Regemat 3D's main competitors?

Direct peers on record are 3D Biotek, CELLINK (BICO), Allevi (3D Systems), Aspect Biosystems, RegenHU, Poietis, Organovo and Brinter. GeSiM (Gesellschaft für Silizium-Mikrosysteme) is listed as a regional player. Stratasys is listed as a broad incumbent.

Does Regemat 3D have an API?

No public API is recorded for Regemat 3D.

What industry is Regemat 3D in?

Regemat 3D's product category is 3D Bioprinting and Tissue Engineering Equipment. Its primary akta.pro industry code is IMAAAAAG, Bioprinting & Biofabrication Systems (Tissue/Cell Printing Hardware), with a secondary code of HLAAAGAC, 3D Bioprinting & Biofabrication. Its NAICS code is 541714 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ApplicantesJóvenes empresas para envejecer mejorThe United Nations projects that one in six people globally will be over 60 years old by 2030, rising to 22% of the world population by 2050, driving rapid growth in the $23 billion global longevity therapy market expanding at 7.8% annually. At the World Longevity Forum, several Spanish startups showcased innovations spanning genetic predisposition testing (N-GENE, present in 180+ clinics), cellular senescence detection (Celentis Sensores), AI-powered early atherosclerosis diagnosis via retinal imaging (Horus ML), gut microbiome analysis with personalized nutrition (Biotasmart), and clinical 3D bioprinting for bone and tissue repair (Regemat 3D, Xcure Surgical). The companies are scaling toward broader commercialization, with Horus ML planning entry into Mexico and Chile and Xcure Surgical targeting the US market by late 2027.Regemat3DRegemat3D – Creating live, changing futuresThe article is a promotional overview of Regemat3D, highlighting its integrated platform for functional tissue engineering that combines 3D bioprinting with advanced bioreactors. It details specific product lines including the BIO V1 and REG4Life bioprinters, as well as the BMAP® Knee Bioreactor designed for osteochondral regeneration. The text emphasizes the company's capability to transform printed scaffolds into living functional tissues for regenerative medicine research.MorningstarRegemat 3D to Distribute VitroInk® Bioinks: A Strategic Distribution for Advanced Bioprinting Solutions in EuropeTheWell Bioscience announced a non-exclusive distribution of its VitroINK bioinks through Regemat 3D, a 3D bioprinting company. VitroINK is a xeno-free bioink that allows direct cell mixing and bioprinting without UV, heat, or crosslinking agents. The partnership aims to enhance Regemat 3D's product portfolio for tissue engineering and regenerative medicine.YahooRegemat 3D to Distribute VitroInk® Bioinks: A Strategic Distribution for Advanced Bioprinting Solutions in EuropeRegemat 3D will non-exclusively distribute TheWell Bioscience's VitroINK bioinks, a xeno-free biofunctional system that allows direct cell mixing and bioprinting without UV, heat, or crosslinking agents. The partnership aims to enhance Regemat 3D's product portfolio and offer comprehensive bioprinting solutions to researchers and clinicians worldwide.PR NewswirePUZZLE X Frontier Material Innovations: From Human Tissue Printers To Air-Purifying Bikes And Graphene ConcreteThe first edition of PUZZLE X, a new initiative focused on Materials Deep Tech for sustainable solutions, will be held in Barcelona from November 16 to 18, 2021, organized by Fira de Barcelona, the Advanced Material Future Preparedness Taskforce (AMPT), and Mobile World Capital Barcelona. The event will showcase innovations including 3D bioprinted human tissues by Spanish company REGEMAT 3D, air-purifying bicycle attachments by German startup Planet Airo, graphene-enhanced products by Swedish company Grafren AB and UK-based Versarien, and plant-based meat alternatives by Barcelona-based Novameat. Multiple frontier material innovations addressing environmental challenges aligned with UN Sustainable Development Goals will be presented across the three-day event.